Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0346
-0.0013
(-3.62%)
At close: April 1 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Eric Schlorff | CEO, President & Executive Director | 420k | -- | 1974 |
| Colonel Kevin Chung FACP, M.D. | Chief Medical Officer | 350k | -- | 1973 |
| Dr. H. David Humes M.D. | Co-Founder and Managing Director | 135.71k | -- | -- |
| Mr. David A. Green CPA, M.B.A. | Chief Financial Officer | -- | -- | 1963 |
| Mr. Tom Mullen | Vice President of Operations & Product Development | -- | -- | -- |
| Mr. Tim Varacek | Senior VP of Commercial & Business Operations | -- | -- | -- |
| Mr. Sai P. Iyer Ph.D. | Senior Vice President of Medical Affairs & Research | -- | -- | -- |
SeaStar Medical Holding Corporation
3513 Brighton Boulevard
Suite 410
Denver, CO 80216
United States
- Sector:
- Healthcare
- Industry: Biotechnology
Description
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Corporate Governance
SeaStar Medical Holding Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
NRSNW NeuroSense Therapeutics Ltd.
0.1751
-14.71%
CELUW Celularity Inc.
0.0410
+2.50%
SVA Sinovac Biotech Ltd.
6.47
0.00%
NBTX Nanobiotix S.A.
3.5800
+1.13%
COEP Coeptis Therapeutics Holdings, Inc.
9.47
+1.07%
LSB LakeShore Biopharma Co., Ltd
2.4000
-0.83%
OSRHW OSR Holdings, Inc.
0.0351
-12.25%
MAZE Maze Therapeutics, Inc.
9.90
-10.08%
RLFTF Relief Therapeutics Holding SA
2.6300
0.00%
DMAC DiaMedica Therapeutics Inc.
3.7500
-1.06%